Jin Xing Qi
Chairman at HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Net worth: 1 654 M $ as of 2024-04-29
Jin Xing Qi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Chairman | 2002-12-31 | - |
| Zhejiang Management Research | Corporate Officer/Principal | 2010-02-23 | - |
| Hangzhou Pute Equity Investment Co. Ltd. | Chairman | 2011-04-06 | - |
Hangzhou Binjiang Investment Holding Co., Ltd.
 Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding company based in Hangzhou, China. | Director/Board Member | - | - |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
 Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The company is based in Hangzhou, China. | Director/Board Member | - | - |
Career history of Jin Xing Qi
Former positions of Jin Xing Qi
| Companies | Position | Start | End |
|---|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | 2011-04-07 | - |
| Founder | 2011-04-07 | - |
Training of Jin Xing Qi
| Zhejiang University | Masters Business Admin |
Statistics
International
| China | 8 |
Operational
| Director/Board Member | 3 |
| Chairman | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Finance | 4 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| Private companies | 5 |
|---|---|
| Zhejiang Management Research | |
| Hangzhou Pute Equity Investment Co. Ltd. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
Hangzhou Binjiang Investment Holding Co., Ltd.
Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding company based in Hangzhou, China. | Miscellaneous |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The company is based in Hangzhou, China. | Finance |
- Stock Market
- Insiders
- Jin Xing Qi
- Experience